Nectar Lifesciences Buyback 2025 vs VLS Finance Buyback 2025

Comparison between Nectar Lifesciences Buyback 2025 and VLS Finance Buyback 2025.

Buyback Details

Nectar Lifesciences Buyback 2025 is a Tender Offer buyback proposed to list at BSE, NSE while VLS Finance Buyback 2025 is a Tender Offer proposed to list at BSE, NSE.

 Nectar Lifesciences Ltd.Vls Finance Ltd.
LogoNectar Lifesciences Buyback 2025 LogoVLS Finance Buyback 2025 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE, NSE
Face Value₹1 per share₹10 per share
Buyback Price₹27 per share₹380 per share
Issue Size3,00,00,000 shares26,31,578 shares
Issue Size (Amount)₹81.00 Crores₹100.00 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,32,51,651
General Category for all other Eligible Shareholders25 Equity Shares out of every 103 Fully paid-up Equity Shares held on the Record Date.1,67,48,349
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders39 Equity Shares out of every 415 Fully paid-up Equity Shares held on the Record Date.3,94,737
General Category for all other Eligible Shareholders23 Equity Shares out of every 248 Fully paid-up Equity Shares held on the Record Date.21,36,841
RegistrarKfin Technologies Ltd.RCMC Share Registry Pvt.Ltd.
Lead ManagersMaster Capital Services Ltd.New Berry Capitals Pvt.Ltd.
Necessity of the buyback
  • The buyback will help the company to return surplus cash to its shareholders holding equity shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders.
  • The buyback will help the company to optimize the capital structure;
  • The Buyback, which is being implemented through the Tender Offer route as prescribed under the SEBI Buyback Regulations, would involve allocation of the number of equity shares as per their entitlement or 15% of the number of equity shares to be bought back, whichever is higher, reserved. The company believes that the reservation for small shareholders would benefit a large number of the Company's public shareholders, who get classified as "Small Shareholders, as per regulations 2(i)(n) of the SEBI Buyback Regulations.
  • The buyback may help in improving financial ratios like earnings per share, return on capital employed, and return on equity, by reduction in the equity base, thereby leading to long-term increase in shareholders' vlaue; and
  • The buyback gives an option to the shareholders holding Equity shares of the company, who can choose to participate and get cash in lieu of Equity shares to be accepted under the Buyback offer or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the buyback offer, without additional investment.
  1. The Buyback is expected to achieve the following objectives:
    1. Optimise return to shareholders:
    2. Enhance overall shareholders' value; and
    3. Optimise the capital structure.
  2. The Buyback will not in any manner impair the ability of the Company to pursue growth opportunities or meet its cash requirements for business operations.
  3. The Buy Back gives an option to the shareholders holding Equity Shares of the Company, to either (i) choose to participate and get cash in lieu of Equity Shares to be accepted under the Buy Back Offer or (ii) choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buy Back Offer, without additional investment.

Buyback Timetable

Nectar Lifesciences Buyback 2025 and VLS Finance Buyback 2025 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Nectar Lifesciences Buyback 2025 Buyback record date is Dec 24, 2025. VLS Finance Buyback 2025 Buyback record date is Dec 12, 2025.

 Nectar Lifesciences Ltd.Vls Finance Ltd.
Record DateDec 24, 2025Dec 12, 2025
Offer Open DateDec 31, 2025Dec 18, 2025
Offer Closure DateJan 06, 2026Dec 24, 2025
Last date for receipt of tender formsJan 06, 2026Dec 24, 2025
Finalisation of buybackJan 12, 2026Dec 30, 2025
Last Date for settlment of bidsJan 13, 2026Jan 01, 2026
Last Date for extinguishment of sharesJan 22, 2026Jan 12, 2026

Financial Details and Other Relevent Information

Comparison of Nectar Lifesciences Buyback 2025 and VLS Finance Buyback 2025 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Nectar Lifesciences Ltd.Vls Finance Ltd.
Financial

Company Financials (Restated Consolidated)

Nectar Lifesciences Ltd.'s revenue decreased by 1% and profit after tax (PAT) dropped by 2376% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Total Income11.301,674.971,698.661,566.85
Profit After Tax-1.01-113.684.99-24.18
NET Worth716.87956.111,069.251,064.59
Reserves and Surplus694.44933.681,046.821,042.17
Total Borrowing458.85582.02635.54753.83
Amount in ₹ Crore

Vls Finance Limited Financial Information (Restated Consolidated)

Vls Finance Limited's revenue decreased by 74% and profit after tax (PAT) dropped by 86% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 2024
Assets2,710.613,552.43
Total Income108.08418.20
Profit After Tax46.20324.33
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.75 14.67
Oct-2025 16.01 13.31 14.26
Sep-2025 17.03 14.07 15.15

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2023 224.95 209.15 217.65
Jan-2024 234.50 210.15 222.46
Jan-2025 244.95 218.90 230.04
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2025 16.99 13.71 14.64
Oct-2025 15.76 13.10 14.18
Sep-2025 16.99 14.03 15.12

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Jan-2023 225.20 206.80 217.57
Jan-2024 233.49 212.21 222.69
Jan-2025 245.00 219.01 230.04

Compare with others

Compare: